Popular on Rezul
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 207
- PulteGroup expands Northeast Florida presence with Oakmere coming soon to Mandarin - 116
- Cre8ive Realty Highlights Waterfront Property Expertise Across Southwest Florida - 108
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8 - 101
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not
- The Drywall Helper Introduces a Versatile Approach to Measuring and Supporting Drywall
- Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
Similar on Rezul
- NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
- NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
- Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
- Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
- Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
- HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
- AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
- $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
- Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
- Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
2025 R&D Spending And Intensity Benchmarks
Rezul News/10745053
VIRGINIA BEACH, Va. - Rezul -- Schonfeld & Associates, Inc. has released the latest edition of its annual study R&D Ratios & Budgets. The new research report covers R&D spending and intensity in fiscal 2025 by more than 2,700 individual publicly traded companies within 280 industries. R&D Intensity, a key performance indicator, expresses a company's investment in research and development relative to its revenue. It is defined as the ratio of R&D spending to revenue.
The pharmaceutical industry continues to be the biggest R&D investor in fiscal 2025 with budgets of drug companies increasing slightly to $195 billion. Software companies contributed a total of over $132 billion to this investment pool.
The biggest single R&D investor in 2025 was Amazon at over $108 billion, followed by Alphabet at $61 billion, and then Meta, Microsoft and Apple at over $31 billion each. Firms involved with digital content are investing much more heavily than those in more traditional arenas.
Pharmaceutical firms continued significant R&D spending in 2025. Merck, the top spender at $15.7 billion, is followed by Johnson & Johnson, Astrazeneca, AbbVie, Eli Lilly, Pfizer, and Novartis each spending over $10 billion. The biotech industry, led by Amgen, decreased R&D spending by nearly 8% to $36 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3.5 billion, an increase of 2% over 2024.
More on Rezul News
R&D budgets of semiconductor makers grew to over $93 billion, an increase of over 13%. Nvidia had the largest R&D budget, $18 billion, a 43% increase from 2024. Major suppliers to the infrastructure of the Internet cloud continue robust R&D spending to remain competitive.
The 2025 R&D spending of the automotive industry, led by Stellantis, Toyota, Honda, Ford and General Motors each spending over $8 billion, was up over 24% from the 2024 total with industry revenues up over 2%.
R&D Ratios & Budgets is an essential reference presenting R&D spending and intensity information published annually by Schonfeld & Associates, Inc. The study is based on 10-K annual report information submitted to the U.S. Securities & Exchange Commission.
R&D Ratios & Budgets contains information for each of the over 2,700 individual publicly traded companies. Fiscal year 2025 revenue and R&D spending are listed as well as annual growth rates of each. R&D intensity for 2025 is presented along with the lowest and highest R&D Intensity ratio during the past five years. The range of values gives an insight into the stability of the firm's commitment to funding R&D as well as its direction.
More on Rezul News
The industry summary section within R&D Ratios & Budgets presents for each of 280 industries: total fiscal year 2025 revenue and R&D spending as well as annual growth rates of each. The industry R&D intensity ratio for 2025 is listed so that an individual company's value can be compared to the value for the industry as a whole and to answer the question: Is this company leading or lagging its peers in prioritizing innovation?
To allow for further investigation, two Excel datafiles are available for purchase along with the PDF report. Each contains five years of revenue, R&D spending and R&D intensity information. One file contains company data and the other industry information.
The 2026 edition of the R&D Ratios & Budgets PDF study is $395 and the study along with Excel datafiles is $495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information or to place an order: 800-205-0030 or visit https://www.saibooks.com/product/r-d-ratios-budgets-2 for immediate download.
The pharmaceutical industry continues to be the biggest R&D investor in fiscal 2025 with budgets of drug companies increasing slightly to $195 billion. Software companies contributed a total of over $132 billion to this investment pool.
The biggest single R&D investor in 2025 was Amazon at over $108 billion, followed by Alphabet at $61 billion, and then Meta, Microsoft and Apple at over $31 billion each. Firms involved with digital content are investing much more heavily than those in more traditional arenas.
Pharmaceutical firms continued significant R&D spending in 2025. Merck, the top spender at $15.7 billion, is followed by Johnson & Johnson, Astrazeneca, AbbVie, Eli Lilly, Pfizer, and Novartis each spending over $10 billion. The biotech industry, led by Amgen, decreased R&D spending by nearly 8% to $36 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3.5 billion, an increase of 2% over 2024.
More on Rezul News
- Men Moving Mountains Expands Full-Service Moving Options in Boone, NC and the High Country
- Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
- NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
- Elavo Star System Introduces Innovative Approach to Professional Tree Trunk Cleaning
- Corner Property Management AAMC Begins Community Management Services at Townhomes at Cambridge
R&D budgets of semiconductor makers grew to over $93 billion, an increase of over 13%. Nvidia had the largest R&D budget, $18 billion, a 43% increase from 2024. Major suppliers to the infrastructure of the Internet cloud continue robust R&D spending to remain competitive.
The 2025 R&D spending of the automotive industry, led by Stellantis, Toyota, Honda, Ford and General Motors each spending over $8 billion, was up over 24% from the 2024 total with industry revenues up over 2%.
R&D Ratios & Budgets is an essential reference presenting R&D spending and intensity information published annually by Schonfeld & Associates, Inc. The study is based on 10-K annual report information submitted to the U.S. Securities & Exchange Commission.
R&D Ratios & Budgets contains information for each of the over 2,700 individual publicly traded companies. Fiscal year 2025 revenue and R&D spending are listed as well as annual growth rates of each. R&D intensity for 2025 is presented along with the lowest and highest R&D Intensity ratio during the past five years. The range of values gives an insight into the stability of the firm's commitment to funding R&D as well as its direction.
More on Rezul News
- OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
- Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
- "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
- Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
- Titan Pressure Washing Shows Florida Homeowners How Improper Roof Cleaning Can Damage Tile Roofs
The industry summary section within R&D Ratios & Budgets presents for each of 280 industries: total fiscal year 2025 revenue and R&D spending as well as annual growth rates of each. The industry R&D intensity ratio for 2025 is listed so that an individual company's value can be compared to the value for the industry as a whole and to answer the question: Is this company leading or lagging its peers in prioritizing innovation?
To allow for further investigation, two Excel datafiles are available for purchase along with the PDF report. Each contains five years of revenue, R&D spending and R&D intensity information. One file contains company data and the other industry information.
The 2026 edition of the R&D Ratios & Budgets PDF study is $395 and the study along with Excel datafiles is $495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information or to place an order: 800-205-0030 or visit https://www.saibooks.com/product/r-d-ratios-budgets-2 for immediate download.
Source: Schonfeld & Associates, Inc.
Filed Under: Business
0 Comments
Latest on Rezul News
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
- DBF Viewer 2000 v9.32 Adds New Control for Data Export
- Pulte announces Canopy Cove, Pulte's first-ever townhome community in St. Johns County
- Becky Krook Expands Colorado Real Estate Resources for Denver Metro and Boulder County
- David Weekley Homes Luxury Community in Georgia's City of Woodstock Nears Closeout
- Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
- CompStak Launches Agent Connect, an MCP Server for Verified Commercial Real Estate Data
- Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
- Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
- HomeReach Launches Free Tool to Simplify Affordable Housing Search in Essex County
- Verosocial LLC Relaunches Timeshare+ With Expanded Ownership and Vacation Value Calculators
- Home Prices Fall as Sales RiseāMortgage Rates Jump Back Above 7%
- Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
- Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
- Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
- PXV Multifamily Acquires 196-Unit Virginia Beach Apartment Community
- Boston Landscapers Report Growing Demand For Sustainable Designs
- Massachusetts Homeowners: Is Your Roof Ready for Winter?
- Derek Cook's Roofing Encourages Homeowners to Prepare for Fall Weather
- Boston Industrial Solutions Expands Product Offering with Pad Printing Pads and Silicone for Custom Pad Manufacturing
